Status:
COMPLETED
Sarcopenia in Axial and Peripheral Spondyloarthropathies
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Spondylarthropathy
Sarcopenia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Spondylarthropathies (SpA) are among the most common chronic inflammatory rheumatisms in adults, responsible for a muscular loss or sarcopenia which can be very disabling, not much documented in the l...
Eligibility Criteria
Inclusion
- Men and women, 18 to 80 years old
- Hospitalized or attending the rheumatology department for spondyloarthopathy.
Exclusion
- no signed consent
- Immobilization for a period of more than 15 days during the last 3 months
- pregnant or breastfeeding woman
- Not affiliated to the national healthcare insurance
- difficulty in understanding French
- psychiatric disorder
Key Trial Info
Start Date :
November 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 4 2018
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT03319264
Start Date
November 2 2017
End Date
July 4 2018
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Rhumatologie - Hôpital Edouard Herriot
Lyon, France, 69003